XML 68 R40.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2014
Fair Value Disclosures [Abstract]  
Financial Assets and Liabilities Measured at Fair Value on Recurring Basis
The following fair value hierarchy table presents information about the Company’s financial assets and liabilities measured at fair value (in thousands):
 
Assets and Liabilities Measured at
Fair Value on a Recurring Basis
December 31, 2014
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
Financial instruments owned, at fair value:
 
 
 
 
 
 
 
Equities (1)
$
2,479,910

 
$

 
$

 
$
2,479,910

Listed options
144,586

 

 

 
144,586

U.S. government and Non-U.S. government obligations
22,983

 

 

 
22,983

Corporate debt (2)
59,832

 

 

 
59,832

Foreign currency forward contracts

 
60

 

 
60

Total Financial instruments owned, at fair value
2,707,311

 
60

 

 
2,707,371

Investment in CME Group (3)
4,435

 

 

 
4,435

Deferred compensation investments (3)

 
868

 

 
868

Investment in Deephaven Funds (3)

 
146

 

 
146

Total assets held at fair value
$
2,711,746

 
$
1,074

 
$

 
$
2,712,820

Liabilities

 

 

 

Financial instruments sold, not yet purchased, at fair value:
 
 
 
 
 
 
 
Equities (1)
$
2,069,342

 
$

 
$

 
$
2,069,342

Listed options
115,362

 

 

 
115,362

U.S. government obligations
18,953

 

 

 
18,953

Corporate debt (2)
82,050

 

 

 
82,050

Total liabilities held at fair value
$
2,285,707

 
$

 
$

 
$
2,285,707

(1) 
Equities of $743.1 million have been netted by their respective long and short positions by CUSIP number.
(2) 
Corporate debt instruments of $0.3 million have been netted by their respective long and short positions by CUSIP number.
(3) 
Investment in CME Group, Deferred compensation investments and Investment in Deephaven Funds are included within Investments on the Consolidated Statements of Financial Condition.

 
Assets and Liabilities Measured at
Fair Value on a Recurring Basis
December 31, 2013
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
Financial instruments owned, at fair value:
 
 
 
 
 
 
 
Equities (1)
$
2,298,785

 
$

 
$

 
$
2,298,785

Listed options
339,798

 

 

 
339,798

U.S. government and Non-U.S. government obligations
40,053

 

 

 
40,053

Corporate debt
43,203

 

 

 
43,203

Total Financial instruments owned, at fair value
2,721,839

 

 

 
2,721,839

Securities on deposit with clearing organizations (2)
170,235

 

 

 
170,235

Investment in CME Group (3)
3,925

 

 

 
3,925

Deferred compensation investments (3)

 
117

 

 
117

Investment in Deephaven Funds (3)

 
1,958

 

 
1,958

Total assets held at fair value
$
2,895,999

 
$
2,075

 
$

 
$
2,898,074

Liabilities
 
 
 
 
 
 
 
Financial instruments sold, not yet purchased, at fair value:
 
 
 
 
 
 
 
Equities (1)
$
1,851,006

 
$

 
$

 
$
1,851,006

Listed options
252,282

 

 

 
252,282

U.S. government obligations
15,076

 

 

 
15,076

Corporate debt
42,122

 

 

 
42,122

Foreign currency forward contracts

 
5,014

 

 
5,014

Total liabilities held at fair value
$
2,160,486

 
$
5,014

 
$

 
$
2,165,500

(1) Equities of $697.9 million have been netted by their respective long and short positions by CUSIP number.
(2)  
Securities on deposit with clearing organizations consist of U.S. government obligations and are recorded within Receivable from brokers, dealers and clearing organizations on the Consolidated Statements of Financial Condition.
(3) Investment in CME Group, Deferred compensation investments and Investment in Deephaven Funds are included within Investments on the Consolidated Statements of Financial Condition.